-
BIAL - PORTELA & CA. S.A. et al v. Hetero Labs Limited et al DC
- 1:20-cv-00780
- D. Del.
- Judge: Colm F. Connolly
+1
- Filed: 06/09/2020
- Closed: 07/29/2020
- Latest Docket Entry: 07/30/2020
- PACER
- Docket updated daily
3
Plaintiffs
3
Defendants
4
Accused
Products
3
Patents-in-Suit
51
Days in
Litigation
-
BIAL - PORTELA & CA. S.A. et al v. Hetero Labs Limited et al DC
- 1:20-cv-00780
- D. Del.
- Judge: Colm F. Connolly
+1
- Filed: 06/09/2020
- Closed: 07/29/2020
- Latest Docket Entry: 07/30/2020
- PACER
- Docket updated daily
Causes of Action
Infringement
Declaratory Judgment
Patent Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Hetero Labs Limited
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Eslicarbazepine Acetate Tablets 200mgEslicarbazepine Acetate Tablets 400mgEslicarbazepine Acetate Tablets 600mgEslicarbazepine Acetate Tablets 800 mg | US 10,675,287 B2 | All Asserted Claims |
Infringement
Entry 14
|
| Eslicarbazepine Acetate Tablets 200mgEslicarbazepine Acetate Tablets 400mgEslicarbazepine Acetate Tablets 600mgEslicarbazepine Acetate Tablets 800 mg | US 10,695,354 B2 | All Asserted Claims |
Infringement
Entry 14
|
| Eslicarbazepine Acetate Tablets 200mgEslicarbazepine Acetate Tablets 400mgEslicarbazepine Acetate Tablets 600mgEslicarbazepine Acetate Tablets 800 mg | US 10,702,536 B2 | All Asserted Claims |
Infringement
Entry 14
|
Hetero Labs Limited Unit V
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Eslicarbazepine Acetate Tablets 200mgEslicarbazepine Acetate Tablets 400mgEslicarbazepine Acetate Tablets 600mgEslicarbazepine Acetate Tablets 800 mg | US 10,675,287 B2 | All Asserted Claims |
Infringement
Entry 14
|
| Eslicarbazepine Acetate Tablets 200mgEslicarbazepine Acetate Tablets 400mgEslicarbazepine Acetate Tablets 600mgEslicarbazepine Acetate Tablets 800 mg | US 10,695,354 B2 | All Asserted Claims |
Infringement
Entry 14
|
| Eslicarbazepine Acetate Tablets 200mgEslicarbazepine Acetate Tablets 400mgEslicarbazepine Acetate Tablets 600mgEslicarbazepine Acetate Tablets 800 mg | US 10,702,536 B2 | All Asserted Claims |
Infringement
Entry 14
|
Hetero USA Incorporated
- 3 Details
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| Eslicarbazepine Acetate Tablets 200mgEslicarbazepine Acetate Tablets 400mgEslicarbazepine Acetate Tablets 600mgEslicarbazepine Acetate Tablets 800 mg | US 10,675,287 B2 | All Asserted Claims |
Infringement
Entry 14
|
| Eslicarbazepine Acetate Tablets 200mgEslicarbazepine Acetate Tablets 400mgEslicarbazepine Acetate Tablets 600mgEslicarbazepine Acetate Tablets 800 mg | US 10,695,354 B2 | All Asserted Claims |
Infringement
Entry 14
|
| Eslicarbazepine Acetate Tablets 200mgEslicarbazepine Acetate Tablets 400mgEslicarbazepine Acetate Tablets 600mgEslicarbazepine Acetate Tablets 800 mg | US 10,702,536 B2 | All Asserted Claims |
Infringement
Entry 14
|
